A detailed history of Citigroup Inc transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Citigroup Inc holds 19,615 shares of ARCT stock, worth $330,316. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19,615
Previous 14,935 31.34%
Holding current value
$330,316
Previous $363,000 25.34%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$18.08 - $25.38 $84,614 - $118,778
4,680 Added 31.34%
19,615 $455,000
Q2 2024

Aug 12, 2024

SELL
$24.35 - $44.39 $2.96 Million - $5.39 Million
-121,472 Reduced 89.05%
14,935 $363,000
Q1 2024

May 10, 2024

BUY
$31.23 - $42.99 $2.73 Million - $3.76 Million
87,535 Added 179.11%
136,407 $4.61 Million
Q4 2023

Feb 09, 2024

SELL
$17.71 - $32.97 $149,702 - $278,695
-8,453 Reduced 14.75%
48,872 $1.54 Million
Q3 2023

Nov 09, 2023

BUY
$25.44 - $37.35 $96,163 - $141,183
3,780 Added 7.06%
57,325 $1.46 Million
Q2 2023

Aug 10, 2023

SELL
$23.94 - $32.36 $1.88 Million - $2.54 Million
-78,546 Reduced 59.46%
53,545 $1.54 Million
Q1 2023

May 11, 2023

BUY
$14.72 - $23.97 $581,101 - $946,263
39,477 Added 42.63%
132,091 $3.17 Million
Q4 2022

Feb 09, 2023

SELL
$14.14 - $23.06 $1.14 Million - $1.86 Million
-80,512 Reduced 46.5%
92,614 $1.57 Million
Q3 2022

Nov 10, 2022

BUY
$13.05 - $22.13 $603,588 - $1.02 Million
46,252 Added 36.46%
173,126 $2.57 Million
Q2 2022

Aug 10, 2022

BUY
$12.26 - $31.17 $987,653 - $2.51 Million
80,559 Added 173.94%
126,874 $2 Million
Q1 2022

May 12, 2022

SELL
$17.64 - $39.57 $1.47 Million - $3.3 Million
-83,509 Reduced 64.32%
46,315 $1.25 Million
Q4 2021

Feb 10, 2022

BUY
$34.2 - $47.56 $2.23 Million - $3.1 Million
65,188 Added 100.85%
129,824 $4.81 Million
Q3 2021

Nov 10, 2021

BUY
$27.88 - $58.25 $1.8 Million - $3.77 Million
64,636 New
64,636 $3.09 Million

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $448M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.